ClinicalTrials.gov
ClinicalTrials.gov Menu

Rapidly Absorbable Versus Non-absorbable Sutures for Mohs Surgery Repair on the Face: a Randomized Controlled Split-scar Study (RAVNAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01932359
Recruitment Status : Completed
First Posted : August 30, 2013
Last Update Posted : April 13, 2015
Sponsor:
Information provided by (Responsible Party):
University of British Columbia

Brief Summary:
This study aims to compare scar outcomes between rapidly absorbable and non-absorbable sutures (stitches) for the closure of wounds after skin cancer removal on the face.

Condition or disease Intervention/treatment Phase
Scars Other: rapidly absorbable suture (Vicryl Rapide) Other: non-absorbable suture (Ethilon) Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 105 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Rapidly Absorbable Versus Non-absorbable Sutures for Mohs Surgery Repair on the Face: a Randomized Controlled Split-scar Study (RAVNAS)
Study Start Date : October 2013
Actual Primary Completion Date : March 2014
Actual Study Completion Date : November 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Scars

Arm Intervention/treatment
Active Comparator: rapidly absorbable suture (Vicryl Rapide) Other: rapidly absorbable suture (Vicryl Rapide)
Active Comparator: non-absorbable suture (Ethilon) Other: non-absorbable suture (Ethilon)



Primary Outcome Measures :
  1. Stony Brook Scar Evaluation Scale (SBSES) score [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Mohs surgical wound on the face
  • Wound greater than or equal to 4 cm in length
  • Subject is willing and capable of cooperating to the extent and degree required by the protocol and will be able to come for follow-up assessments
  • Subject has read and signed Subject Information and Informed Consent Form

Exclusion Criteria:

  • Surgical wound less than 4 cm in length
  • Surgical site outside of face
  • Subject to be be treated with radiation therapy after surgery
  • Subject is not willing or able to attend for follow-up assessments

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01932359


Locations
Canada, British Columbia
Department of Dermatology and Skin Science, UBC, Vancouver General Hospital
Vancouver, British Columbia, Canada, V5Z 4E8
Sponsors and Collaborators
University of British Columbia
Investigators
Principal Investigator: David Zloty, MD University of British Columbia

Responsible Party: University of British Columbia
ClinicalTrials.gov Identifier: NCT01932359     History of Changes
Other Study ID Numbers: H13-01961
First Posted: August 30, 2013    Key Record Dates
Last Update Posted: April 13, 2015
Last Verified: April 2015

Keywords provided by University of British Columbia:
Scar outcome
Mohs surgery
face